Track the GENETIC SIGNATURES LIMITED share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the supervision of ASX. Market capitalisation: €21.6m. The latest transaction was disclosed on 1 September 2026 (Other). Among the most active insiders: Caroline Waldron. All data is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 26,430 of 29,055 companies
20.8
score / 100
Value
2
Quality
39
FCF yld-61%
Earn yld-93%
EV/EBITDA·
ROE-33%
Gross mgn49%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
GENETIC SIGNATURES LIMITED is a company listed on the Australian Securities Exchange, specializing in the development of diagnostic tests based on DNA technology. It focuses on the rapid and accurate detection of pathogens in clinical samples.